GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Evotec SE (XSWX:EVT) » Definitions » Pretax Margin %

Evotec SE (XSWX:EVT) Pretax Margin % : -11.93% (As of Dec. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Evotec SE Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Evotec SE's Pre-Tax Income for the three months ended in Dec. 2023 was CHF-22.7 Mil. Evotec SE's Revenue for the three months ended in Dec. 2023 was CHF189.9 Mil. Therefore, Evotec SE's pretax margin for the quarter that ended in Dec. 2023 was -11.93%.

The historical rank and industry rank for Evotec SE's Pretax Margin % or its related term are showing as below:

XSWX:EVT' s Pretax Margin % Range Over the Past 10 Years
Min: -20.49   Med: 9.74   Max: 38.34
Current: -13.1


XSWX:EVT's Pretax Margin % is ranked worse than
70.42% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 4.39 vs XSWX:EVT: -13.10

Evotec SE Pretax Margin % Historical Data

The historical data trend for Evotec SE's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evotec SE Pretax Margin % Chart

Evotec SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.70 5.16 38.34 -20.49 -10.31

Evotec SE Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -24.94 -7.28 -12.00 -15.24 -11.93

Competitive Comparison of Evotec SE's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Evotec SE's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evotec SE's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Evotec SE's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Evotec SE's Pretax Margin % falls into.



Evotec SE Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Evotec SE's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-76.005/736.944
=-10.31 %

Evotec SE's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-22.657/189.853
=-11.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Evotec SE  (XSWX:EVT) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Evotec SE Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Evotec SE's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Evotec SE (XSWX:EVT) Business Description

Address
Essener Bogen 7, Manfred Eigen Campus, Hamburg, DEU, 22419
Evotec SE is a drug discovery partnership company providing solutions to pharmaceutical & biotechnology companies, academic institutions as well as foundations, and not-for-profit organizations. The company offers its services in the area of neuronal diseases, diabetes & its complications, pain, inflammation, oncology, infectious diseases, respiratory & fibrosis, rare disease, and women's health. Its business segments are EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone drug discovery services on a typical fee-for-service basis or integrated drug discovery collaborations. The EVT Innovate segment develops drug discovery programs and assets, both internally and through academic collaborations. The majority of its revenue is derived from the EVT Execute segment.

Evotec SE (XSWX:EVT) Headlines